FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013350571> ?p ?o ?g. }

• W2013350571 endingPage "S261" @default.
• W2013350571 startingPage "S261" @default.
• W2013350571 abstract "Top of pageAbstractIntroduction: Despite great advances in vector development, most standard rAAV-2 vectors still lack the target cell specificity required for an efficient in vivo application. In addition, the gene transfer efficiency in many promising target cells (e.g.: peripheral blood progenitor cells (PBPC)) is low. Thus, designing gene therapy protocols for diseases like chronic myelogenous leukemia (CML) remained difficult, as standard rAAV-2-based vectors lack both the required gene transfer efficiency and selectivity. A recent advancement in vector development (Muller et al., 2003) now allows the generation of rAAV capsid mutants that offers higher target cell specificity and transduction efficiency. This method was applied to obtain a CML-targeted rAAV vector and was tested on a panel of leukemic cell lines, as well on primary CML material.Material and Methods: Performing latter method on the CML cell line K562 (4 selection rounds), several mutant CML-targeted rAAV2 capsid clones were obtained, cloned into an rAAV2 helper plasmid and for each of the mutants rAAV2-eGFP vector stocks were produced. Titers were verified using our real time PCR-based titration assay. To determine efficiency and specificity, a panel of leukemic (CML and AML) and non-leukemic cell lines, as well primary human CML and PBPC cells were transduced with these vectors. Mock, normal rAAV2 and random mutant clone-transduced cells served as controls. Transduction of primary human CML and PBPC cells was confirmed using FACS-sorted GFP+ cells with subsequent bcr-abl-FISH or FACS analysis for GFP/CD34+ co- expression, respectively.Results: Transduction of a panel of six leukemic cell lines with the CML-targeted rAAV2 vectors (moi 100 iu) resulted in an over 10-fold increase of gene transfer efficiency compared to random mutant and standard rAAV2 vectors; gene transfer rates of >60% were obtained. In primary human cells, for both CML (n=4) and PBPC (n=2), an increase in gene transfer was observed (CML: AAV2: 2.4 |[plusmn]| 0.2 vs AAV2-cml: 5.1 |[plusmn]| 1.6 (p=0.04). CD34+: AAV2: 3.2 |[plusmn]| 0.9 vs AAV2-cml: 8.5 |[plusmn]| 4.3 (p>0.05)). All transduced cell were positive for either the BCR-ABL fusion gene (CML) or the PBPC marker CD34. In contrast, gene transfer of the mutant CML-targeted rAAV2 vectors into non-leukemic cell lines resulted in a reduction in gene transfer efficiency compared to standard rAAV2 vectors (<50%).Conclusion: In this study, we were able to generate a CML-targeted rAAV2 vector, which was able to transduce leukemic cell lines and primary human CML cells with significant higher efficiency and specificity than standard rAAV2 vectors. The development of these vectors holds promise for future clinical applications." @default.
• W2013350571 created "2016-06-24" @default.
• W2013350571 creator A5003598598 @default.
• W2013350571 creator A5010375570 @default.
• W2013350571 creator A5015972472 @default.
• W2013350571 creator A5023767037 @default.
• W2013350571 creator A5030876392 @default.
• W2013350571 creator A5063686794 @default.
• W2013350571 creator A5084314339 @default.
• W2013350571 creator A5091140526 @default.
• W2013350571 date "2006-01-01" @default.
• W2013350571 modified "2023-09-26" @default.
• W2013350571 title "677. Generation and Application of an Efficient Chronic Myelogenous Leukemia (CML)-Targeted Recombinant Adeno-Associated Virus (rAAV) Vector: New Therapeutic Options?" @default.
• W2013350571 doi "https://doi.org/10.1016/j.ymthe.2006.08.754" @default.
• W2013350571 hasPublicationYear "2006" @default.
• W2013350571 type Work @default.
• W2013350571 sameAs 2013350571 @default.
• W2013350571 citedByCount "0" @default.
• W2013350571 crossrefType "journal-article" @default.
• W2013350571 hasAuthorship W2013350571A5003598598 @default.
• W2013350571 hasAuthorship W2013350571A5010375570 @default.
• W2013350571 hasAuthorship W2013350571A5015972472 @default.
• W2013350571 hasAuthorship W2013350571A5023767037 @default.
• W2013350571 hasAuthorship W2013350571A5030876392 @default.
• W2013350571 hasAuthorship W2013350571A5063686794 @default.
• W2013350571 hasAuthorship W2013350571A5084314339 @default.
• W2013350571 hasAuthorship W2013350571A5091140526 @default.
• W2013350571 hasBestOaLocation W20133505711 @default.
• W2013350571 hasConcept C104317684 @default.
• W2013350571 hasConcept C159047783 @default.
• W2013350571 hasConcept C203014093 @default.
• W2013350571 hasConcept C2776960273 @default.
• W2013350571 hasConcept C2778107364 @default.
• W2013350571 hasConcept C2778461978 @default.
• W2013350571 hasConcept C40767141 @default.
• W2013350571 hasConcept C502942594 @default.
• W2013350571 hasConcept C54355233 @default.
• W2013350571 hasConcept C71924100 @default.
• W2013350571 hasConcept C86803240 @default.
• W2013350571 hasConcept C92087593 @default.
• W2013350571 hasConceptScore W2013350571C104317684 @default.
• W2013350571 hasConceptScore W2013350571C159047783 @default.
• W2013350571 hasConceptScore W2013350571C203014093 @default.
• W2013350571 hasConceptScore W2013350571C2776960273 @default.
• W2013350571 hasConceptScore W2013350571C2778107364 @default.
• W2013350571 hasConceptScore W2013350571C2778461978 @default.
• W2013350571 hasConceptScore W2013350571C40767141 @default.
• W2013350571 hasConceptScore W2013350571C502942594 @default.
• W2013350571 hasConceptScore W2013350571C54355233 @default.
• W2013350571 hasConceptScore W2013350571C71924100 @default.
• W2013350571 hasConceptScore W2013350571C86803240 @default.
• W2013350571 hasConceptScore W2013350571C92087593 @default.
• W2013350571 hasLocation W20133505711 @default.
• W2013350571 hasOpenAccess W2013350571 @default.
• W2013350571 hasPrimaryLocation W20133505711 @default.
• W2013350571 hasRelatedWork W2316159389 @default.
• W2013350571 hasRelatedWork W2362815864 @default.
• W2013350571 hasRelatedWork W2368374462 @default.
• W2013350571 hasRelatedWork W2387639147 @default.
• W2013350571 hasRelatedWork W2392849191 @default.
• W2013350571 hasRelatedWork W2418775839 @default.
• W2013350571 hasRelatedWork W2437098622 @default.
• W2013350571 hasRelatedWork W2601821497 @default.
• W2013350571 hasRelatedWork W3120659120 @default.
• W2013350571 hasRelatedWork W77600851 @default.
• W2013350571 hasVolume "13" @default.
• W2013350571 isParatext "false" @default.
• W2013350571 isRetracted "false" @default.
• W2013350571 magId "2013350571" @default.
• W2013350571 workType "article" @default.